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Purpose: Few large series document surgical outcomes for patients with pararenal abdominal aortic aneurysms (PAAAs),
defined as aneurysms including the juxtarenal aorta or renal artery origins that require suprarenal aortic clamping. No
standard endovascular alternatives presently exist; however, future endovascular branch graft repairs ultimately must be
compared with the gold standard of open repair. To this end, we present a 10-year experience.
Methods: Between 1993 and 2003, 3058 AAAs were repaired. Perioperative variables, morbidity, and mortality were
retrospectively assessed. Renal insufficiency was defined as a rise in the concentration of serum creatinine by>0.5mg/dL.
Factors predicting complications were identified bymultivariate analyses. Morbidity and 30-day mortality were evaluated
with multiple logistic regression analysis.
Results: Of a total of 3058 AAA repairs performed, 247 were PAAAs (8%). Mean renal ischemia time was 23 minutes
(range, 5 to 60 minutes). Cardiac complications occurred in 32 patients (13%) , pulmonary complications in 38 (16%),
and renal insufficiency in 54 (22%). Multivariate analysis associated myocardial infarction with advanced age (P  .01)
and abnormal preoperative serum creatinine (>1.5 mg/dL) (P  .08). Pulmonary complications were associated with
advanced age (P .03), renal artery bypass (P .02), increased mesenteric ischemic time (P .01), suprarenal aneurysm
repair (P < .0008), and left renal vein division (P  .01). Renal insufficiency was associated with increased mesenteric
ischemic time (P  .001), supravisceral clamping (P  .04), left renal vein division (P  .04), and renal artery bypass
(P  .0002), but not renal artery reimplantation or endarterectomy. New dialysis was required in 3.7% (9/242).
Abnormal preoperative serum creatinine (>1.5 mg/dL) was predictive of the need for postoperative dialysis (10% vs 2%;
P .04). Patients with normal preoperative renal function had improved recovery (93% vs 36%; P .0002). The 30-day
surgical mortality was 2.5% (6/247) but was not predicted by any factors, and in-hospital mortality was 2.8% (7/247).
Median intensive care and hospital stays were 3 and 9 days, respectively, and longer stays were associated with age at
surgery (P  .007 and P  .0002, respectively) and any postoperative complication.
Conclusions: PAAA repair can be performed with low mortality. Renal insufficiency is the most frequent complication,
but avoiding renal artery bypass, prolonged mesenteric ischemia time, or left renal vein transection may improve
results. ( J Vasc Surg 2006;43:921-8.)Pararenal abdominal aortic aneurysms (PAAAs) are
characterized by the absence of normal aorta between the
upper extent of the aneurysm and the renal arteries.1 Con-
temporary series report that 8% to 20% of AAAs are parare-
nal by classification, both juxtarenal and suprarenal.2-6 In
the United States, Food and Drug Administration-approved
endovascular grafts are not yet available to treated aortic
branches; therefore, repair of PAAAs requires open aortic
reconstruction.
The surgical risks of PAAA repair are understandably
greater than standard open infrarenal aneurysm repairs
because of obligatory renal ischemia, possible mesenteric
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ogy, and the inherent danger of atheroembolization.6-7
Renal insufficiency has been reported as the most frequent
complication owing to suprarenal clamping.3 In addition,
concomitant renal reconstruction is often required during
PAAA repair, potentially increasing the risk of renal failure.
Mortality is 5% to 8% after PAAA repair compared with 1%
to 3% after elective infrarenal repair at high-volume tertiary
referral centers.8-10
The technique of open AAA repair is waning in vascular
surgery practices and training programs as more thoracic
and abdominal aortic aneurysms are treated with endograft
techniques. As endovascular grafts with branch fenestra-
tions or branch grafts become a viable option in managing
PAAAs, it is increasingly important to determine whether
endovascular options represent an improvement on current
open techniques. We present our current decade of experi-
ence with pararenal aneurysms to delineate mortality and
morbidity and to define factors that affect outcome.
METHODS
Between January 1, 1993, and December 31, 2003,
3058 AAAs were repaired at the Mayo Clinic. This study
reviewed pararenal aneurysms that were treated electively
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ruptured AAAs were excluded. Data were collected retro-
spectively through electronic and manual chart reviews in
all patients after appropriate authorization.
Aneurysm definitions. PAAAs are defined as aortic
aneurysms that extend to the juxtarenal aorta or to the base
of the superior mesenteric artery (SMA) involving the renal
artery origins that require aortic clamping between the
suprarenal aorta and the supraceliac aorta to safely perform
the repair. Aneurysms are further subdivided into juxtarenal
and suprarenal categories. Juxtarenal aneurysms are those
that extend up to but not including the renal arteries, but
require clamping above one or both renal arteries. Supra-
renal aneurysms involve a renal artery origin but also extend
above the renal origins to the base of the SMA, requiring
aortic clamping above the SMA or the celiac artery. The
assignment of pararenal aneurysms into the study was based
on preoperative radiographic findings and on specific de-
tails found at operation. The study excluded type IV tho-
racoabdominal aneurysms and paravisceral aneurysms.
Preoperative variables. Coronary artery disease was
detected by cardiac stress testing, previous myocardial in-
farction on 12-lead electrocardiograph (Q wave or ST-T
wave changes) or patients with a history of coronary artery
bypass. Congestive heart failure was defined clinically by a
cardiologist, after hospital admission for acute exacerbation
of congestive heart failure, or by an ejection fraction of
30%. All patients underwent preoperative cardiac evalua-
tion with stress echocardiography, nuclear studies, or cor-
onary catheterization.
Chronic obstructive pulmonary disease (COPD) was
defined as patients requiring inhaler or steroid treatment or
those with COPD based on pulmonary function studies.
No patients in this study required home oxygen therapy
preoperatively.
Preoperative renal insufficiency was present if serum
creatinine values were 1.6 to 3.6 mg/dL. Preoperative
diabetes, hyperlipidemia, and hypertension were defined by
patients undergoing active medical or dietary treatment.
Cerebrovascular disease was considered present in those
with a history of stroke, transient ischemic attack, or carotid
endarterectomy.
Operative conditions and reconstructive techniques.
A transperitoneal midline incision with an infracolic aortic
exposure was used in most cases. All patients were system-
ically treated with 70 to 100 U/kg of heparin before aortic
cross-clamping. Activated clotting time was routinely used
to confirm adequate systemic anticoagulation.
Renal protection in most cases included intravenous
mannitol (12.5 to 25 g) and furosemide (40 to 60 mg) to
induce diuresis before the initial aortic cross-clamp place-
ment, followed by direct renal artery instillation with cold
heparinized normal saline or lactated Ringer’s solution.
When necessary, the left renal vein was transected, leaving
intact the lumbar renal, adrenal, and gonadal veins. Aortic
cross-clamps were placed supraceliac, supra-SMA, suprare-
nal, or inter-renal (between two main renal arteries).Methods of reconstructing the proximal anastomosis
included suturing the graft to the juxtarenal aorta in an
end-to-end fashion or spatulating the graft to incorporate
the renal arteries into the suture line. The renal arteries and
visceral vessels, when indicated, were routinely isolated
individually and clamped before aortic cross-clamp place-
ment.
At the time of reperfusion, the aortic cross-clamp was
released first to allow forward flushing of blood into the
aortic graft followed by visceral reperfusion and then renal
reperfusion. Renal artery endarterectomy, reimplantation,
or renal artery bypass was used if the patient had concom-
itant renal artery stenosis or the renal artery origin was in an
aneurysmal segment, or both.
Operative times were recorded in minutes. Renal isch-
emia times refer to total renal occlusion from the time of
the aortic clamp placement until the last renal artery was
reperfused. In the case of renal artery bypass, the ischemia
time for each kidney was recorded separately. In cases
where the clamp was placed inter-renal, the ischemia time
refers to a single renal ischemia time. The volume of blood
transfused during the operation was recorded in units and
included both cell saver and banked blood.
Intra-operative completion studies included ultra-
sound for all patients undergoing endarterectomy, and
either ultrasound or ultrasonic flow measurements (mL/
min), or both, for patients with renal artery bypass. Intra-
operative imaging was not routine in patients with renal
artery reimplantation.
Morbidity and mortality. The primary study end
point was 30-day mortality, and the secondary end points
were major cardiac, pulmonary, and renal complications.
Myocardial infarction (MI) was established by using bio-
chemical criteria and electrocardiographic evidence ofmyo-
cardial injury on a 12-lead electrocardiogram (Q wave or
ST-T wave changes). Patients were considered to have an
MI based on enzyme criteria alone. Pulmonary failure was
defined as ventilator dependence of 72 hours, need for
postoperative reintubation, clinical data or culture confir-
mation of pneumonia, or the need for tracheostomy.
The normal serum creatinine value was chosen as1.5
mg/dL.3 Renal insufficiency was defined as a rise in serum
creatinine concentration by .5 mg/dL when peak postop-
erative creatinine levels were compared with baseline preoper-
ative creatinine. Patients with postoperative renal insufficiency
were further categorized as persistent renal insufficiency vs
recovered renal insufficiency.Persistent renal insufficiency was
defined as failure of creatinine to return to30% of normal
baseline serum creatinine values at the time of hospital
discharge. Renal function was considered recovered if the
discharge serum creatinine value was 1.5 mg/dL or was
30% of the baseline value. The need for temporary or
permanent dialysis was recorded.
Data analysis. Continuous variables are summarized
with the mean  standard deviation or median (range).
Categoric variables are summarized with frequencies and
percentages.
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stay and intensive care unit (ICU) length of stay excluded
seven patients who died in-hospital. These analyses used
Spearman’s rank correlation with P values in the case of
continuous variables and Wilcoxon rank-sum tests in the
case of binary variables.Multiple linear regressionmodeling
of these two outcomes was performed on the ranks of the
values because of strongly skewed distributions for the
length-of-stay variables. Analysis of binary outcomes such
as 30-day death, temporary postoperative dialysis, pulmo-
nary complications, cardiac complications, and postopera-
tive renal insufficiency was performed by using univariate
and multiple linear regression analysis. These analyses ex-
cluded two patients who died intraoperatively; renal insuf-
ficiency analyses also excluded three patients on dialysis
preoperatively.
Stepwise and backward model selection procedures
were used for both the linear and logistic multiple regres-
sion models. Univariately significant variables or variables
identified by these model selection procedures were con-
sidered candidate variables for the final multiple regression
model. Variables meeting the criteria for statistical signifi-
cance (P  .1) were retained in the final multiple variable
models. Values of P  .05 were considered statistically
significant for all analyses. Statistical analysis was performed
using SAS (version 9) software (SAS Institute, Inc,Cary,NC).
RESULTS
Demographics. Pararenal aortic aneurysms comprised
8.1% (247/3058) of all AAAs, of which 204 were juxtare-
nal aneurysms and 43 were suprarenal aneurysms. There
were 203 men (82%) and 44 women (18%), with a mean
age of 73.0 years (range, 44 to 96 years).
Preoperative variables. Coronary artery disease was
present in 157 patients (64%), with 33% of all patients
undergoing previous coronary artery bypass, and 37 % with
previous myocardial infarction (Table I). Ejection fraction
was documented in 180 patients and ranged from 15% to
82% (mean, 55%  14%); 10 patients (6%) had an ejection
fraction of 30%. Eighty-six (35%) patients had an estab-
lished diagnosed of COPD, and 45 (18%) patients had
Table I. Preoperative comorbidities
Comorbidities Patients, n (%)
Congestive heart failure 26 (11)
Coronary artery disease 157 (64)
Previous myocardial infarction 91 (37)
Hypertension 201 (82)
Hyperlipidemia 162 (66)
Cerebrovascular disease 41 (17)
COPD 87 (35)
Preoperative dialysis 3 (1)
Serum creatinine 1.5 mg/dl 45 (18)
Diabetes mellitus 27 (11)
History of tobacco use 203 (83)
COPD, Chronic obstructive pulmonary disease.preoperative renal insufficiency. Of the 243 patients withrecorded tobacco use history, 163 (67%) were past smok-
ers, 39 (16%) actively smoked, and 41 (17%) never smoked.
All other comorbidities represented active medical issues
for the patients preoperatively. Risk factors for atheroscle-
rotic vascular disease and other comorbidities are outlined
in Table I.
Aneurysm etiology was described in all but one patient
and included degenerative in 218 (89.0%), inflammatory in
8 (7.4%), pseudoaneurysm in 4 (1.6%), chronic dissection
in 3 (1.2%), and infected in 2 (0.82%). Nineteen (8%)
patients had previous aortic surgery, and 104 (42%) had a
history of aneurysms in either the iliac or infrainguinal
arteries. No patients in this group had had an endograft
repair.
Operative management. Thirty-three patients (13%)
had symptomatic aneurysms; seven were treated urgently
24 hours of presentation. Mean aneurysms size was 6.4
cm (median, 6 cm; range, 3.0 to 11.4 cm). Surgical ap-
proach was midline, transabdominal in 200 patients (81%),
medial visceral rotation via a midline incision in 30 (13%),
via a retroperitoneal incision in 14 (6%), and via a thoraco-
abdominal incision in two (0.8%).
Twenty patients (8%) required left renal vein division.
Five left renal veins were divided and reanastomosed. They
were not considered in the group of patients with left renal
vein division. Distal reconstructions were tube grafts in 111
(45%) and bifurcated in 135 (54%). Clamp placement and
renal and mesenteric ischemia times are summarized in
Table II.
Concomitant renal artery reconstruction was required
in 53 patients (21%) (Table II) There were 62 renal artery
procedures in 53 patients. Seven patients had two renal
arteries revascularized, and one had three arteries revascu-
larized. Renal artery reimplantation was performed in 10%
(25/247), renal artery endarterectomy in 9% (23/247),
and renal artery bypass in 5% (13/247). Mean and median
renal ischemia times (minutes) for renal endarterectomy
were 29 and 30; for reimplantation, 29 and 27; and for
Table II. Operative variables
Operative variables Patients, n (%)
Clamp location
Supraceliac 34 (14)
Supra-SMA 49 (20)
Suprarenal 164 (67)
Bilateral 105
Interrenal 59
Renal artery procedures* 53/245 (21)
Reimplantation 25
Endarterectomy 24
Bypass 13
Renal ischemia time (minutes) 23.2  9.7 (5–60)†
Mesenteric ischemia time (minutes)‡ 25.5  7.8 (8–46)†
SMA, Superior mesenteric artery.
*62 procedures in 53 patients.
†Mean  SD (range).
‡83 patients with supraceliac or supra-SMA clamp location.renal artery bypass, 39 and 37. The mean operative time
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mean blood volume transfused intraoperatively. Eight pa-
tients (3.2%) had inferior mesenteric artery reimplantations.
Morbidity and mortality. Morbidity included MI in
32 (13%), pulmonary complications in 38 (16%), and renal
insufficiency in 54 (22%) (Table III). Dialysis was required
in 3.7% (9/242) of postoperative patients, excluding three
patients with chronic renal insufficiency who were receiving
dialysis preoperatively. Thirty-four patients had a unilateral
renal artery procedure. Bilateral renal procedures (revascu-
larization, endarterectomy, or reimplantation, or a combi-
nation) were done in 19 patients, and 18 survived. Of the
survivors, six (33%) had postoperative renal insufficiency
compared with 14 (41%) of 34 patients who had the
unilateral procedure (P  .77). Two percent (5/202) of
the patients in the normal preoperative serum creatinine
group required temporary dialysis vs 10% (4/41) of those
with abnormal preoperative values (P  .04). No patients
required new postoperative permanent dialysis. Signifi-
cantly more patients (P  .0002) recovered renal function
if they had a normal preoperative serum creatinine level
(93%, 40/43) vs those that did not (4/11).
Three patients had significant visceral ischemia that re-
sulted in death. Two patients had clinically suspected bowel
ischemia that was diagnosed as mild, superficial disease on
flexible sigmoidoscopy. These patients were managed with
hydration and intravenous antibiotics, and had no short-term
sequelae before dismissal from the hospital.
Thirty-daymortality was 2.5% (6/247), and in-hospital
mortality was 2.8% (7/247). Two patients died from intra-
operative cardiac arrest. Three patients died, one each on
postoperative day 2, 8, and 24, of complications of visceral
ischemia. The first patient died on postoperative day 2 after
re-exploration identified extensive visceral infarction. The
other two patients underwent colon resections and ulti-
mately died of complications of multisystem organ failure.
Another patient died on day 7 of multisystem organ failure
that resulted in respiratory arrest. The final patient died on
day 73 after multiple chronic infections and failure to thrive.
Median ICU and hospital stay were 3 days and 9 days.
Themean ICU and hospital lengths of stay were 5.2 (range,
2 to 72) and 11.3 days (range, 2 to 372).
Clinical predictors. MI was associated multivariately
with increased age (P  .01) and a preoperative serum
Table III. Postoperative complications
Morbidity* Patients, n (%)
Pulmonary complication 38 (16)
Myocardial infarction 32 (13)
Renal insufficiency† 54 (22)
Dialysis‡
Temporary 9 (4)
Permanent 0
*Excluding 2 patients who died intraoperatively.
†Excluding 3 patients who were on preoperative dialysis.creatinine level of 1.5 mg/dL (P  .08) (Table IV,Appendix, online only). Pulmonary complications were
associated with advanced age (P .03), renal artery bypass
(P  .02), increased mesenteric ischemic time (P  .01),
suprarenal aneurysm repair (P .0008), and left renal vein
division (P  .01) (Table IV; Appendix, online only).
Postoperative renal insufficiency was associated with in-
creased mesenteric ischemic time (P  .001), supravisceral
clamping (P  .04), and renal artery bypass (P  .0002),
but not renal artery reimplantation or endarterectomy, and
left renal vein division (P  .04) (Table IV; Appendix,
online only).
Because only 9 patients required temporary postoper-
ative dialysis, statistical assessment of associated variables
was limited primarily to univariate analysis. Several variables
had a significant or nearly significant univariate association
with need for temporary postoperative dialysis: age at sur-
gery (odds ratio [OR], 1.5 per 5-year increase; 95% confi-
dence interval [CI], 1.0 to 2.4; P  .06), preoperative
serum creatinine level of 1.5 mg/dL (OR, 4.4; 95% CI
1.1 to 17.1; P  .03), suprarenal aneurysm (OR, 4.0; 95%
CI, 1.0 to 15.5; P  .046), renal artery bypass (OR, 19.9;
95% CI, 4.6 to 86.9; P .0001), renal ischemia time (OR,
1.4 per 5-minute increase; 95% CI, 1.1 to 1.9; P  .009),
supravisceral clamp location (OR. 7.4; 95% CI, 1.5 to 36.4;
P  .01), and amount of blood transfused intraoperatively
(OR, 1.18 per 1 unit; 95% CI, 1.07 to 1.31; P  .0007).
The small number of postoperative dialysis events (9) made
it impossible to perform a complete multivariable analysis
due to low power for assessing more than a single predictor
variable. However, an exploratory analysis including the
univariately significant variables in a single model showed
that the variables of renal artery bypass (P  .0004),
Table IV. Multivariable logistic regression results
Outcome and variables
Odds ratio
(95% CI) P
Pulmonary complications*
Age, per 5 years 2.7 (1.1, 6.9) .03
Suprarenal aneurysm vs juxtarenal 1.6 (1.2, 2.1) .0008
Renal artery bypass 4.9 (1.2, 19.0) .02
Left renal vein division 1.2 (1.1, 1.4) .01
Mesenteric ischemia time,
per 5 min† 4.4 (1.3, 14.4) .01
Cardiac complications*
Age, per 5 years 1.4 (1.1, 1.8) .01
Abnormal pre-op SCr
(1.5 mg/dL) 2.1 (0.9, 5.1) .08
Renal insufficiency*‡
Supravisceral clamp 0.1 (0.01, 0.9) .04
Renal artery bypass 14.4 (3.6, 57.3) .0002
Left renal vein division 3.0 (1.1, 8.6) .04
Mesenteric ischemia time, per 5 min† 1.8 (1.3, 2.7) .001
CI, Confidence interval; SCr, serum creatinine.
*Excluding 2 patients who died intraoperatively.
†Patients without supraceliac or suprasuperior mesenteric artery clamp type
were given a value of zero for mesenteric ischemia time in multivariable
model.
‡Excluding 3 patients on dialysis preoperatively.supravisceral clamp location (P  .02), and age at surgery
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dialysis when included together in the model.
A subgroup analysis of the patients with previous AAA
repair (19 patients, 8%) showed that they had no increase in
morbidity or mortality compared with primary PAAA re-
pair; therefore, they were included with the entire group.
Of the eight patients who had inferior mesenteric artery
reimplantations, only one had major complications unre-
lated to mesenteric ischemia. This group was too small to
identify associations with morbidity or mortality.
No associations were found with multivariate analysis
between preoperative characteristics or surgical data that
predicted 30-day mortality, although the small number of
six events limited the analysis of variables. However, the
amount of blood transfused intraoperatively was signifi-
cantly higher among patients who later died30 days than
for those who survived 30 days (14  4.5 units vs 5.4 
4.3 units, respectively, P  .003). Although not reaching
statistical significance, the following variables also showed a
trend toward association with 30-day death: preoperative
serum creatinine level of 1.5 mg/dL (OR, 4.7; 95% CI,
0.9 to 24.3; P  .06), renal artery endarterectomy (OR,
5.0; 95% CI, 0.9 to 28.7; P .07), and supravisceral clamp
location (OR, 4.1; 95% CI, 0.7 to 22.9; P  .11).
Multivariate associations were identified with in-hospital
mortality. The amount of blood transfused was significantly
higher among patients who died in-hospital compared with
those who survived to discharge (mean 13.4 4.2 units vs
5.4  4.3 units, P  .0007). Also, the following variables
were significantly associated with increased odds of in-
hospital death: preoperative serum creatinine1.5 mg/dL
(OR, 6.5; 95% CI, 1.4, 3.0; P  .02), supravisceral clamp
location (OR, 5.2; 95% CI, 1.0 to 27.4; P  .05), and
mesenteric ischemia time (OR per 5 minutes, 1.3; 95% CI,
1.0 to 1.7; P  .04).
Multiple regression modeling suggested that the fol-
lowing variables were independently associated with ICU
length of stay: age at surgery (P .007), renal artery bypass
(P  .01), postoperative pulmonary complication (P 
.0001), postoperative cardiac complication (P  .01), and
postoperative renal insufficiency (P  .06). The multiple
regression model demonstrated hospital length of stay was
associated with aneurysm type (P  .02), age at surgery
(P  .0002), renal ischemia time (P  .04), supravisceral
clamp location (P  .02), postoperative pulmonary com-
plication (P  .0001), postoperative cardiac complication
(P  .05), and postoperative renal insufficiency (P  .02).
DISCUSSION
Pararenal aneurysms comprise a small but not insignif-
icant portion (8% to 20%) of all AAAs. As more infrarenal
aneurysms are repaired by endovascular techniques, PAAAs
represent an increasing percentage of patients undergoing
open aortic aneurysm repair at tertiary referral centers.4
Although several series document surgical outcomes, many
reports are difficult to interpret when juxtarenal, pararenal,
suprarenal, or even type IV thoracoabdominal aneurysms
are lumped in a single study.2-8,10-12 Our goal was to studya well-defined group of patients who required suprarenal or
supravisceral aortic clamp placement to repair an AAA and
to assess outcomes and factors affecting outcomes.
In 1986, Crawford et al13 reported the first series of
juxtarenal aneurysms, with a mortality rate of 7.9% and
dialysis dependency in 8%. The University of California San
Francisco (UCSF) experience reported by Jean-Claude et
al3 in 1999 has provided the largest series of 257 patients.
The authors concluded that although they are more com-
plex than infrarenal AAA, PAAA repairs are performed with
similar mortality rates but increased renal morbidity. A low
incidence of fatal cardiac events was attributed to the lim-
ited use of supraceliac aortic cross-clamping (13%).
In 2002, Sarac et al4 published The Cleveland Clinic
series of 138 juxtarenal aneurysm repairs, with 27% under-
going concomitant renal artery reconstruction. The mor-
tality rate was 5.1%, with two deaths attributed to mesen-
teric ischemia. Postoperative renal insufficiency occurred in
28%. Supraceliac aortic cross-clamping was the only factor
associated with early mortality and was also associated with
postoperative renal insufficiency.
Shortell et al5 recently reported 6% early mortality in a
series of 112 patients, with juxtarenal aneurysm cardiac
complications in 23% and pulmonary in 20%.5 Supraceliac
clamping predominated in this series at 83% (92/112), and
MI caused five of seven deaths. In this study and in the
earlier report of Green et al,14 supraceliac clamping was
considered safe and was the preferred clamp location for
repairing juxtarenal aneurysms.
Our data confirmed the association of supravisceral
clamping with postoperative renal insufficiency and with a
trend for increased mortality. Obviously, patient anatomy
may force the placement of a supraceliac clamp. However,
based on our results and the data from UCSF and The
Cleveland Clinic, we would not recommend the practice of
routine or preferred supraceliac clamping.
Cardiac morbidity in our series was associated only with
advanced age at surgery and an abnormal preoperative
serum creatinine level. These factors are often unavoidable.
When elderly patients with elevated serum creatinine levels
are considered for operation, this increased morbidity should
be discussed during preoperative counseling. As noted by
Messina,7 cardiac complications were not as common as an-
ticipated in this patient group. We have not routinely used
transesophageal echocardiography, although evidence sug-
gests that this may be a useful intraoperative adjunct in high-
risk patients.3,7
Pulmonary complications in the PAAA patients was
associated with increased age, suprarenal aneurysm, renal
artery bypass, left renal vein division, and mesenteric isch-
emic time. These associations are very similar to the risk
factors for predicting renal insufficiency. In the presence of
renal failure, fluid management is often difficult in the
perioperative period, necessitating prolonged intubation.
Renal insufficiency is the most common postoperative
complication and is alarming because of the potential neg-
ative affect it may have on long-term survival.9 Postopera-
tive renal complications are clearly more frequent after
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infrarenal aneurysm repair. Fortunately, most patients re-
cover to nearly normal renal function, and 3% to 6% require
either temporary or permanent dialysis.3 A significant rise in
postoperative serum creatinine levels occurred in 22% in
our series. Of those patients who developed postoperative
renal impairment, 81% recovered before discharge, and
16% required temporary dialysis (3.6% of the entire group).
All patients with sustained renal insufficiency had abnormal
preoperative serum creatinine levels.
The factors multivariately associated with the develop-
ment of postoperative renal insufficiency were supravisceral
clamp placement, renal artery bypass, left renal vein divi-
sion, and increased mesenteric ischemia time. In light of
these associations, we recommend avoiding supravisceral
clamp placement and left renal vein ligation when possible.
In cases of suprarenal aneurysms and circumstances where
one renal artery origin is in a more caudal location, reim-
plantation is often possible. In our practice, we favor reim-
plantation and endarterectomy over bypass in an effort to
decrease renal ischemia time. Within the limits of this
retrospective study, patients with renal artery bypass did
worse, potentially reflecting more complex disease.
Current juxtarenal and pararenal series report 5% to 8%
mortality.6-10 The early mortality rate in our series was 2%.
The mortality rates of pararenal aortic aneurysm repair are
consistently higher than infrarenal repair, which is 1.1% at
the Mayo Clinic and 1% to 3% at other institutions.8
Achieving equivocal results with PAAA repairs outside of
larger vascular centers might be difficult for the inexperi-
enced who seldom treat these AAAs. Perpetuating excellent
surgical results in the future may also be affected by the fact
that up to 60% of AAA repairs can be performed with an
endovascular aneurysm repair, implying that vascular train-
ees get less exposure to open operations.15
Of the six deaths 30 days in this report, two patients
had suprarenal aortic cross-clamping, two were suprames-
enteric, and two were supraceliac. The cause of death in our
report was visceral ischemia in three of six. Although the
numbers were too small to create statistical significance, mes-
enteric ischemia remains a critical concern when treating pa-
tients with PAAAs, as noted in several other series.2-4,16,17
Since not all patients with mesenteric ischemia had pro-
longed mesenteric ischemia times, the role of embolization
cannot be underestimated as a contributor to both mesen-
teric and renal ischemia during PAAA repair.
Accurate preoperative radiographic assessment of the
pararenal aorta to guide appropriate aortic cross-clamp
placement as well as meticulous exposure techniques are
crucial elements to avoid fatal visceral complications and
minimize complications from atheroembolization.2 Of the
three patients reoperated on for visceral ischemia, the pa-
tient with massive bowel ischemia had an acutely occluded
SMA. The other two patients with colon ischemia had had
a previously occluded inferior mesenteric artery not ame-
nable to reimplantation.
Careful attention to superior mesenteric artery circula-
tion is crucial in PAAA repair, including concomitant supe-rior mesenteric artery revascularization in symptomatic pa-
tients. The surgeon must also be cognizant of hypogastric
artery patency and have a low threshold to reimplant the
inferior mesenteric artery to protect the reserve of the
mesenteric circulation.17 Although only eight of our pa-
tients underwent inferior mesenteric artery reimplanta-
tions, an additional 19 patients (8%) had already had had
aortic operation and previous management of the inferior
mesenteric artery.
In our series, length-of-hospital stay after PAAA repair
was not significantly different from what is reported after
infrarenal aortic aneurysm repairs.18 Older age (75 years),
COPD, and poor functional status are known to increase
length of stay after aortic surgery.18-21 Mean length of stay
was prolonged in patients with increased age, supravisceral
aortic cross-clamping, renal artery bypass, left renal vein divi-
sion, and prolonged renal ischemic time. Again, these predic-
tors parallel those for postoperative renal failure, as length of
stay is often prolonged in patients with renal insufficiency.
Endovascular aneurysm repair has been realized in
most aortic segments. PAAAs have limited suitable fixation
and altered reliable sealing of a fenestrated endograft into
visceral vessels.22 The threat of renal complications and
fatal atheroembolization are still problems for endoluminal
therapy, including one of two deaths that occurred in a
recent endovascular series in which fenestrated endografts
were used treat juxtarenal aortic aneurysms.23-25 The de-
velopment of hybrid endovascular and open adjunctive
visceral reconstructive procedures has been recently popu-
larized tominimize the extent of open surgery in aneurysms
involving thoracoabdominal and pararenal segments.24 Ul-
timately, hybrid techniques, and new devices should be
directly compared with the results of open PAAA repair to
determine superiority before universal use.
CONCLUSION
Pararenal abdominal aortic aneurysms can be repaired
with mortality rates that are nearly equal to open infrarenal
aneurysm repairs; however, overall morbidity is greater. We
have demonstrated that advanced age, increasedmesenteric
ischemic time, the need to perform renal artery bypass, and
left renal vein ligation were significant predictors of cardio-
pulmonary and renal complications as well as prolonged
hospital stay. By avoiding these factors when undertaking
open repairs, outcomes from surgical treatment of parare-
nal aortic aneurysms may be improved.
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Dr. Dalsing. Very nice presentation. I just have one question.
It looks like most of your mortality is associated with mesenteric
ischemia, more specifically colonic ischemia. Did you do anything
with the IMA? Was it usually occluded? Did you reimplant it?
Dr. West. Well it was hard to really know how to break
ischemia down into hindgut and foregut. We did reimplant eight
IMAs and those patients did very well, and we feel it is important to
do that. I hope that answers your question. As far as looking at CT
scans, not every patient had a CT scan and it was difficult to tell
from the records whether the IMA was patent in all of these cases
or not. It was something that was an intraoperative observation.
Dr. Greenberg. I enjoyed the presentation as well and have a
couple of questions. Your last conclusion about avoiding suprace-
liac clamping is an interesting conclusion except that generally
supraceliac clamps are applied only when it is required to repair an
aneurysm. Thus, although there may be a desire to avoid such a
clamp position, if anatomy precludes more distal clamp placement,
it would be difficult to criticize such a practice. My question really
relates to the renal issues which I think are the Achilles heel of
aortic operations. The followup that you presented, I assume,
relates to the in-hospital renal function. Much of this is not an
accurate representation of renal dysfunction. When these patientsconsiderably more renal dysfunction than we had originally appre-
ciated. I wanted to know if you had any additional followup on
these patients with respect to their renal dysfunction. Were there
any CT scans that were done to evaluate renal anatomy? Were you
able to assess renal infarcts or other etiologies of the renal issues?
Dr. West. Thank you for your question. Those are excellent
points. Again, this paper is essentially examining these early out-
comes. We do follow up all of our patients at three and six months.
What we noted was that in all these patients that had a significant
creatinine rise which returned completely to normal or within 30%
of baseline at discharge, none of these patients came back with
renal complications that we are aware of. They all did very well. I
realize that is a limitation of the study. We do have long-term
survival data and renal function data that we do have, but I don’t
have that for this paper.
Dr. Shepard. My question has to do with your conclusion
that division of the left renal vein is a factor predictive of a poor
outcome. I’m wondering if in fact division of the left renal vein is a
marker for complexity of the operative procedure or whether you
feel that division of the left renal vein really leads to some delete-
rious effects. Obviously if the latter is the case, then utilization of a
left flank retroperitoneal approach would avoid division of the left
renal vein and lead to improved outcomes.
JOURNAL OF VASCULAR SURGERY
May 2006928 West et alDr.West.Thank you for your question. That’s a great point. It’s
hard to know exactly. I believe it is a marker for a more proximal
aneurysm and often was divided for a more difficult case. It was
interesting that there was some surgeon selectivity in that, sowe don’tpatients with left renal vein division and 6 of those 20 had some renal
insufficiency postoperatively and 3 of those had renal artery proce-
dures done which may have some influence on that but 3 did not, so
that remains statistically significant. I’m not able to fully answer thatknow the exact answer to that, but we do know that there were 20 but I think a marker is certainly a plausible answer to that.
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Variable
Pulmonary
complications*
OR (95% CI) P
Cardiac
complications*
OR (95% CI) P
Renal
insufficiency*†
OR (95% CI) P
Age, per 5 years 1.4 (1.1, 1.8) .006 1.5 (1.1, 1.9) .005 0.9 (0.8, 1.1) .48
Male gender 0.8 (0.3, 1.9) .59 2.2 (0.6, 7.6) .21 1.6 (0.7, 3.8) .30
Congestive heart failure 1.4 (0.5, 4.0) .51 1.9 (0.6, 5.4) .25 1.7 (0.7, 4.3) .22
Coronary artery disease 0.8 (0.4, 1.5) .43 1.8 (0.8, 4.1) .19 1.4 (0.7, 2.6) .35
Cerebrovascular disease 0.7 (0.3, 2.0) .52 1.9 (0.8, 4.6) .15 0.8 (0.4, 2.0) .70
History of cancer 0.9 (0.4, 2.1) .88 1.1 (0.5, 2.5) .82 0.8 (0.4, 1.6) .50
Preop SCr, per 0.5 mg/dL 1.1 (0.8, 1.5) .48 1.2 (0.9, 1.6) .18 1.5 (1.0, 2.0) .03
Abnormal pre-op SCr (1.5 mg/dl) 1.9 (0.8, 4.2) .13 2.6 (1.1, 6.0) .03 1.4 (0.6, 3.0) .39
Suprarenal aneurysm (vs juxtarenal) 4.8 (2.3, 10.4) .0001 1.1 (0.4, 3.0) .78 1.4 (0.7, 3.1) .33
Supravisceral clamp 3.4 (1.7, 6.9) .0008 1.1 (0.5, 2.4) .80 2.7 (1.4, 5.0) .002
Renal artery bypass 5.4 (1.7, 17.0) .004 1.3 (0.3, 6.0) .76 14.0 (3.7, 53.1) .0001
Renal artery endarterectomy 1.6 (0.6, 4.6) .39 0.6 (0.1, 6.8) .55 2.0 (0.8, 5.0) .14
Renal artery reimplantation 1.04 (0.3, 3.2) .94 1.9 (0.6, 5.4) .25 1.4 (0.6, 3.6) .47
Any renal artery procedure 3.0 (1.4, 6.3) .004 1.3 (0.6, 3.2) .51 2.9 (1.5, 5.6) .002
Left renal vein division 3.4 (1.2, 9.1) .02 1.8 (0.6, 5.9) .31 2.6 (1.0, 6.6) .05
Renal ischemia time, per 5 min 1.2 (1.04, 1.5) .02 1.1 (0.9, 1.3) .48 1.4 (1.2, 1.6) .0001
Mesenteric ischemia time, per 5 min‡ 1.1 (0.8, 1.6) .39 1.2 (0.8, 1.8) .41 1.7 (1.2, 2.4) .003
SCr, Serum creatinine.
Results reported are odds ratios (OR) and 95% confidence intervals (CI), and P values from logistic regression.
*Excluding 2 patients who died intraoperatively.
†Excluding 3 patients on dialysis preoperatively.
‡Including only patients with supra celiac or suprasuperior mesenteric artery clamp location.
